GM Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
GM Advisory Group's VRTX Position: Q1 2026 in Review
GM Advisory Group reduced its Vertex Pharmaceuticals (VRTX) stake by 4.7% in Q1 2026, selling an estimated $11.7K and leaving 502 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #339.
GM Advisory Group first reported a position in VRTX in Q3 2023 and has held it in 9 quarters since. The position peaked at $278K in Q3 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- GM Advisory Group held 502 shares of Vertex Pharmaceuticals worth $224K as of Q1 2026.
- GM Advisory Group sold 25 Vertex Pharmaceuticals shares in Q1 2026, an estimated $11.7K.
- Vertex Pharmaceuticals made up 0.01% of GM Advisory Group's portfolio in Q1 2026, its #339 holding.
- GM Advisory Group first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
- GM Advisory Group's Vertex Pharmaceuticals position peaked at $278K in Q3 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.